The Victorian Supreme Court has granted cosmetic surgeon Daniel Lanzer an extension to provide discovery in a class action against him and his clinic after hearing he was facing medical issues.
Blooms the Chemist can’t overturn a decision from the Pharmacy Council of NSW blocking the registration of a chemist, with a judge finding there was no evidence Blooms would not have a financial interest in the business.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
ASX-listed biotech 4D Medical has sued competitor Cyclopharm alleging the company made false, misleading and malicious statements about its rival during an online webinar prompted by a “fake” question.
Samsung Bioepis has successfully opposed Janssen’s bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
In the first-ever civil penalty proceedings for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has been ordered to pay $5.8 million over a 2022 data breach that compromised the sensitive personal information of 223,000 customers of its Medlab business.
Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.
The federal government has hit back against a class action by single women and same-sex couples deemed “socially infertile” and denied Medicare rebates for IVF, denying group members were treated less favourably because of their marital status or sexual orientation.
In the first penalty to be handed down for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has agreed to cop a $5.8 million fine over a 2022 data breach that compromised the personal information of 223,000 customers of its Medlab business.
Venture capital firm EVP has added 20 parties to a lawsuit seeking to recoup its $10.4 million investment in Strongroom AI, as a judge extended freezing orders against directors of the med-tech start-up.